RxDoctor Payments Data

Maria Kessell, MD

Family Medicine · Spencer, WVNPI 1508826595

Payments from drug & device makers

$1,188in general payments, 2019–2025

Across 78 payments — averaging $15.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$213
  • Johnson & Johnson$155
  • Pfizer$154
  • AbbVie$148
  • Novo Nordisk$121
  • Abbott$102
  • plus $294 from 13 others

What the payments were for

  • Food & beverage$1,183100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,188 in reported general payments places this provider in the 70th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$1,882
Medicare patients
89
Services billed
147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide99$226,118
XareltoRivaroxaban87$118,572
RybelsusSemaglutide55$113,858
MounjaroTirzepatide68$103,145
JardianceEmpagliflozin66$76,556
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$53,495
FarxigaDapagliflozin Propanediol30$38,367
EliquisApixaban33$38,161
TrulicityDulaglutide19$35,726
LinzessLinaclotide25$33,742
InvokanaCanagliflozin19$30,787
Tresiba Flextouch U-100Insulin Degludec12$29,702
Spiriva RespimatTiotropium Bromide20$19,203
Breo ElliptaFluticasone/Vilanterol12$10,636
Dexlansoprazole DrDexlansoprazole27$8,214

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$121$339,976154 claims
Johnson & JohnsonXarelto, Invokana$155$149,359106 claims
Lilly USA, LLCMounjaro, Trulicity$27$138,87187 claims
GSKTrelegy Ellipta, Breo Ellipta$41$64,13156 claims
AstraZenecaFarxiga$39$38,36730 claims
PfizerEliquis$154$38,16133 claims
AbbVieLinzess, Synthroid$148$37,70380 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Spencer

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →